• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    WuXi AppTec Completes OXGENE Acquisition

    Trends in Solid Oral Dosage Delivery

    Injectable Drug Delivery Trends

    Oral Solids: Market & Technology Trends
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    Federal Equipment Company

    Emergent BioSolutions

    Baxter BioPharma Solutions

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Aphena Pharma Solutions

    Syngene

    Federal Equipment Company

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    CEO Spotlight: Tim J. Mitchell, JD

    Sentry BioPharma Services’ chief executive talks about the company’s business highlights and industry trends.

    CEO Spotlight: Tim J. Mitchell, JD
    Tim Wright, Editor, Contract Pharma10.14.20
    Sentry BioPharma Services is a wholesaler and third party logistics provider of prescription and investigational drug products, medical devices, and active pharmaceutical ingredients (APIs) for the pharmaceutical and medical device industry.

    Sentry’s founders created the contract service organization (CSO) to meet the rapidly growing demand for dedicated and highly-specialized contract GXP storage, labeling, packaging and supply chain management services.

    Tim Mitchell is principal founder of the company and has been at its helm for the past fourteen years. As president and chief executive officer he has guided Sentry from inception through start up and onto profitability and mature growth. Contract Pharma recently had the chance to discuss Sentry’s beginnings and most recent business highlights as well as wider industry trends with Mr. Mitchell.

    Contract Pharma (CP): Since founding Sentry, how has the company evolved from its roots?

    Tim Mitchell (TM): When we began business in May 2007, we approached the market with three validated temperature ranges: +2°C to +8°C (REF); -15°C to -25°C (FRO20) and +15°C to +30°C (AMB) for management and distribution of temperature sensitive biologics, pharmaceutical materials, finished drug product and medical devices. Today we manage products within 9 separate validated temperatures from +20°C to +25°C (CRT) to <-135°C LN2.  The product profiles include finished drug product, APIs, excipients, as well as master cell banks. Further we label, kit and perform secondary packaging on drug products for distribution into 34 countries.

    CP: What are some of Sentry’s most recent business highlights?

    TM: This last 12 months have been crucial to Sentry. Our year-over-year growth rate for the last five years has averaged 34% annually. However, during 2020 we are experiencing a 56% growth in revenues over 2019.

    Highlights include the completed validation of the new Controlled Room Temperature, +20°C to +25°C (CRT) addition with 1,500 pallet spaces, which will grow to 2,000 spaces by 2021, including active relative humidity control. We also added a former DEA caged, continuously monitored, enhanced security Ultra-Low Temperature freezer storage offering as well as custom steel mezzanine and infrastructure for up to 320 x Ultra-Low Temperature (ULT) upright freezers (-50°C, -70°C, -75°C and -80°C), which will be completed in November 2020.

    We are also completing infrastructure build within a new second site for 50 x -80°C ULT freezers in Copenhagen, Denmark by the end of the fourth quarter 2020 and in Indianapolis, construction has commenced on a second 250 x pallet -20C walk in freezer, doubling site capacity and redundancy. Validation is to be completed by the end of first quarter of 2021.

    CP: In which area(s) of Sentry’s business is it observing the greatest growth?

    TM: The Ultra-Low Temperature (ULT) upright freezers with a validated set point of -50°C, -70°C and -80°C represent the greatest growth area. This has been driven by additional large molecule drug approvals and development.

    CP: What are some of the crucial issues impacting pharma manufacturing and supply and logistics providers like Sentry in particular? 

    TM: Crucial issues include the ready supply of -80°C ULT freezers.  Sentry’s normal experience is to receive new units within 3 business days. Today, because of short supply the time for delivery has extended to more than 10 business days.

    In addition, the lack of international airline flights brought about by COVID-19 significantly impacted global drug distribution in the second quarter of 2020. Additional resources brought to bear by international freight carriers has somewhat alleviated this supply disruption.

    CP: Are you seeing more business growth from new ventures or established organizations?

    TM: A majority of Sentry’s growth is coming from its existing client base which stands at 130 pharmaceutical companies. Although some of these clients are small to medium virtual companies, many are large multi-nationals which seek out Sentry’s expertise in managing extremely cold supply chains. We continue to offer a white glove, customized, customer service-oriented experience to all clients, providing support in the areas of most crucial importance, on a per client basis.

    CP: What are some trends in today’s pharma logistics market to keep an eye on?

    TM: Pharmaceutical supply chain infrastructure is experiencing its own stress test, within this newest market trend of COVID-19 vaccine development. Upon commercialization of one or more promising vaccine candidates, the true extent of the effects on market supply and demand for pharma logistics will be clearer. Some things to consider include, end user (hospital, clinics, etc.) infrastructure for reasonable deployment of a finished vaccine, whether at standard or more exotic temperatures, which may not be readily available in the clinic.

    All other commercial and clinical supply chains are vying for the same resources that were available, prior to COVID-19. This has caused a vacuum in certain markets, which Sentry is working to mitigate. Sentry expects to meet and exceed all client needs, though continues to rely upon our trusted qualified vendors for additional support in fulfilling global logistics on time and in temperature. We expect the next 18 months to yield a better picture on the logistics market, going forward.

    CP: How is technology evolving to help logistics providers like Sentry serve clients?

    TM: Sentry continues to utilize cutting edge technologies to mitigate risks associated with movement of high value temperature sensitive materials, globally. Some of these technologies include: advanced manufacturer qualified shipping systems to maintain temperatures for days at a time and active cellular/GPS based temperature logging systems with multi-variable alarming (light, pressure, shock, humidity, location and temperature) to track shipments in real time.

    Technologies such as these, have allowed Sentry to open shipping lanes into the far corners of the globe, with the highest assurance of successful shipment fulfillment, in time and in temperature. We continue to invest in advanced supply chain infrastructure, to ensure Sentry’s clients are receiving best-in-class service and quality.

    CP: What are some of Sentry’s plans for the near future? How about long-term growth plans?

    TM: Sentry’s plan is to closely monitor our clients’ developing needs and seek avenues to fulfill these needs. In 2021 and 2022 we will be adding stability chambers and services to support client research and development; a secondary facility in the U.S. for the repository of ultra-high value material, as risk mitigation; and we’ll continue to build out services in Copenhagen to meet our clients’ EU and ROW service requirements.

    On our longer-term plans, we intend to evaluate additions of further global depots, in support of ROW operations; evaluate the addition of laboratory services for pharmaceutical development; increase Sentry’s consulting capabilities to further assist our clients with regulatory support; and further expand the Indianapolis site to meet market demand.

    CP: Please add anything else you would like to share with our audience about Sentry and/or the markets it serves.

    TM: Sentry is a smaller company that continues to grow, with a nimble and knowledgeable team. We continue to add resources to meet the ever-expanding biologic pharmaceutical supply chain market. We do so with the utmost care, while ensuring all client needs are met with the appropriate response. This allows Sentry to service organizations including the smallest of pharmaceutical development companies, as well as the largest organizations in the world. 

    Tim Mitchell functions as President and Chief Executive Officer for Sentry BioPharma Services. Mr. Mitchell is an attorney, proven entrepreneur and business leader with more than 35 years of expertise in financial planning and management, investment strategy and business development. His professional accomplishments include a documented track record of helping both new ventures and established organizations attain and accelerate profitability. In his role as Chief Executive Officer at Sentry, Mr. Mitchell is responsible for day-to-day management decisions including oversight of all business operations including shipping/receiving, storage, recordkeeping, and quality, and for implementing Sentry’s long and short-term strategic plans. Further, Mr. Mitchell acts as a direct liaison between the Board of Directors and Sentry’s management team.

    Related Features

    • Solid Dosage/Semi-solids
      Hygienic Packaging Technology

      Hygienic Packaging Technology

      Growing consumer demand for health products highlights hygienic packaging.
      John Brown, Vice President of Global Marketing, Selig 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21


    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Pharmaceutical Manufacturing  Equipment Trends

      Pharmaceutical Manufacturing Equipment Trends

      Demand for flexibility remains the driving force behind equipment systems.
      Kristin Brooks, Managing Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Nutraceutical Manufacturing:  Meeting the Challenges of Today, Planning for  Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • 2021 Contract  Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • APIs
      Small Molecule Development Trends

      Small Molecule Development Trends

      A Q&A with Cambrex Edinburgh’s site director, Mark Benger.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • APIs | Cytotoxics and High Potency Manufacturing
      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      A Q&A with Christian Dowdeswell, vice president and head of commercial development for small molecules at Lonza.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Development and manufacture of medicated chewing gum continues to gain momentum.
      Rukayat Adedeji, Contributing Writer 03.01.21

    • APIs
      Small Molecule API CDMO: A Capital Intensive Business?

      Small Molecule API CDMO: A Capital Intensive Business?

      Exploring small molecule API market trends.
      Dr. Michele Jermini and Dr. Enrico Polastro, Contributing Writers 03.01.21


    • Serialization
      Serialization: Level 5 Solution

      Serialization: Level 5 Solution

      Why a Level 5 solution is required for small pharma companies to fully harness serialization investment.
      Steve Wood, President & CEO, Covectra 03.01.21

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • WuXi AppTec Completes OXGENE Acquisition
    • Arcline Investment Acquires ChargePoint Technology
    Breaking News
    • Innoforce and dMed Enter Development Collaboration
    • Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    • Four Female Leaders Appointed to Cell & Gene CDMO
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Gadot Biochemical Launches New Magnesium Ingredients
    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Probiotic Evidenced to Assist Digestive Recovery from a Complex Surgery
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Benjamin Moore Launches COMMAND
    AOC Announces EMEA Price Increase
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety
    Philips, Disney Partner to Improve MRI Experience for Children
    FDA OKs Asensus' Senhance for General Surgery
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Innoforce and dMed Enter Development Collaboration
    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    Four Female Leaders Appointed to Cell & Gene CDMO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    P&G Makes Progress Toward Packaging Circularity in Europe
    Coty Partners with LanzaTech to Introduce Sustainable Ethanol
    Remembering Fred Segal, a Trendsetting Retail Pioneer
    Happi

    Latest Breaking News From Happi

    Coty Partners with LanzaTech to Reduce Its Environmental Impact
    Waterless Beauty, Simplified Routines Shape Clean Beauty at Whole Foods
    Redken Updates Packaging, Adds New Products
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ashland announces PSA price hike in North America
    Arrow Systems and Sihl form flexible packaging partnership
    Flint Group Packaging announces global price increase
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Joa Announces Expandable Absorbent Core Wrap Solution
    Principle Business Enterprises Celebrates 60 Years
    Mann+Hummel Invests in Pamlico Air
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements Relaunches the Luna XD and Orbit Systems
    Coronavirus Triggers Double-Digit Revenue Dropoff at Smith+Nephew
    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login